LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Aug 17, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-08-16

Reporting Person: May Larry Alan (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-16	Common Stock, par value $0.001 per share	A	1500	—	Acquired	64618	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-16	Stock Option (Right to Buy)	$1.90	D	1500	Disposed		Common stock, par value $0.001 per share (1500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	51	Indirect

Footnotes

F1: The reporting person agreed to the cancellation of a total of 1,500 options (originally granted on January 19, 2006 expiring ten years from the date of grant), including the forfeiture of the reload feature contained in the option which entitled the reporting person to a new option grant for the same number of shares as the original option on exercise, in exchange for the granting of 1,500 shares (for which the Company will pay applicable withholding taxes), as approved by the Compensation Committee.